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Red blood cell anomaly of oxalate transport and urinary acidification in
idiopathic calcium-oxalate nephrolithiasis. G. Gambaro, F. Marchini,
M. Bevilacqua, A. Borsaui, B. Baggio, Institute of Internal Medicine
and Respiratory Physiopatology Lab., University Hospital of Padova,
Padova, Italy. We have previously shown that oxalate self-exchange in
red blood cells of many idiopathic renal stone formers is faster than
normal. The molecular abnormality seems to reside in an altered
phosphorylation of band 3 protein, the anion carrier. However, we are
still looking for a well defined link between this red blood cell abnor-
mality and renal stone formation. Since a protein reacting with anti-
band 3 antibodies has been shown in renal tubules, and taking into
account that the anion carrier plays a fundamental role in urinary
acidification, we have tried an indirect answer to the aforementioned
question by evaluating urinary acidification in 28 nephrolithiasic pa-
tients, of whom 15 were carriers of the red blood cell abnormality.
Urinary acidification has been studied by the NH4CI long test and by
determining the urine to plasma pCO2 gradient (U-BpCO2) after bicar-
bonate infusion. The study has shown that 33% of nephrolithiasic
patients with the RBC abnormality presented defect in distal acidifica-
tion, while patients without RBC abnormality acidified normally (x2
5.28; P < 0.025). Furthermore, in patients with RBC an abnormality
was disclosed by a reduced U-B pCO2 gradient (52.29 17.30 sn mm
Hg vs. 68.24 20.43; t = 2.24; P < 0.05). Finally there was an indirect
correlation between net acid excretion and RBC oxalate flux rate (r =
—0.69; P < 0.01). In conclusion, these data seem to support the
evidence of a defect in the anionic transport not only in RBC but also in
renal tubular cells.
Percutaneous transluminal angioplasty (PTA) in the stenosis of artero-
venous fistulas (AVF) of HD-patients: A middle-term follow-up. V. Mioli,
E. Capponi, L. Graziani, V. Lombardo, 0. Raccosta, G. Trivelli, E.
Manfrmni, G. Gaffi, L. Bibiano and E. Bordoni, NephrologicalDepart-
ment of Ancona, Macerata, and Radiological Department of Ancona,
Umberto 1st University Hospital, Ancona, Italy. For evaluating the
indications (and limits) of PTA as a simple and reliable treatment of
AVF stenosis, our middle term results are reported. Twenty-six PTA
(24 distal and 2 proximal AVF) were performed in 20 patients (14 m and
6 1) with a mean age of 60.2 12 years, and dialytic age of 39.6 47
months (range 1—163). The post-anastomotic venous stenosis (24 C.)
were single in 12 cases and multiple in 12 cases. In two cases the
stenosis was on the anastomosis. The mean age of the AVF treated by
PTA was 19.2 23.2 months (range 1—94). The blood flow increased
after PTA from 212 52 to 325 63 mI/mm (P <0.01). In 15 cases PTA
resolved the stenosis and AVF are, at present, working from 7.2 8.2
months (range 1—28). In 10 cases the stenosis relapsed after 6.9 6.1
months (1—22); a second PTA (in 6 cases) or surgical reconstruction (4
cases) were performed. In conclusion, PTA allowed an immediate
recovery in 25 cases (96.2%). The middle-term follow-up (as actuarial
life expectancy) showed a progressive reduction of AVF function, as
follow: 75% after 6 months; 30.1% after 12 months; 25% after 18 months
and 9.1% after 24 months. We suggest that PTA obtains an important
delay time before AVF reconstruction; it has to be considered the first
choice treatment of AVF stenosis.
Relationship between urinary stone disease and arterial pressure in a
sample of the Italian population. M. Cirillo, C. Pannacci, and M.
Laurenzi, Institute of internal Medicine, University of Naples, Naples;
Center for Preventive Medicine, Gubbio (PG); & Center for Epidemi-
ological Research, Merck Sharp & Dohme, Rome, Italy. Spontane-
ously hypertensive rats have hypercalciuria and high incidence of
urinary stone disease (USD). In humans, hypertension is associated
with relative hypercalciuria, while it is not yet established whether it is
also related with USD. The present study deals with this issue,
analyzing data from an epidemiological survey performed in Gubbio, a
town of central Italy, as a representative sample of the entire popula-
tion. Invited participants took part to the study with an excellent
response rate (>84%). In each participant we measured, among other
variables, blood pressure, serum urea and uric acid concentrations,
weight and height, body mass index (weight/height = kg/rn2). Partici-
pants with serum urea >50 mg/dl were excluded from the present
analysis to rule out cases of hypertension secondary to renal failure. A
positive medical history for USD was defined as the presence of at least
one of these criteria: x-ray evidence of USD, urinary stone excretion,
surgical or endoscopical removal of urinary stone. In the participants
with a positive medical history for USD we also measured serum
creatinine, calcium and phosphate concentrations. Hypertension was
defined by a diastolic pressure level falling within the fifth quintile of the
sex- and age-specific distribution curve. Participants on regular and
chronic pharmacological treatment for hypertension were regarded as
hypertensive independently of the observed blood pressure level.
Treated and untreated hypertensives had similar prevalence of USD
(5.01 vs. 5.40%) and they were therefore analyzed together. The entire
group of hypertensives had a prevalence of USD significantly higher
than that of normotensive people (5.22 vs. 3.30%, P < 0.01). The
calculation of the Mantel-Haenszel odds ratio and logistic analysis
indicated that this difference was not due to confounding factors, such
as sex, age, overweight, hyperuricemia. Serum creatinine, calcium and
phosphate concentrations were comparable between hypertensives
with LJSD and normotensives with USD. The results indicate, there-
fore, that the association between hypertension and USD is indepen-
dent of antihypertensive treatment, sex, age, overweight, hyperurice-
mia, renal function and hypercalcemia. This association could be
explained by the relative hypercalciuria previously described in primary
hypertension.
Dopamlne (D) reverses acute cyclosporine A (CsA) nephrotoxlclty.
Micropuncture study in the rat. M. Sabbatini, C. Esposito, L. De
Nicola, F. Uccello, G. Conte, A. Dal Canton, V. E. Andreucci.
Departmentof Nephrology, University of Naples and Reggio Calabria,
Italy. To evaluate the ability of D to neutralize the acute effects of CsA
on glomerular dynamics, three groups of Münich-Wistar rats were
studied by micropuncture: Gr.I (N = 9), normal rats; Gr.II (N = 10),
rats treated with CsA (20 mg/kg i.v.); Gr.III (N = 8), rats treated with
same doses of CsA and then with a vasodilating dosage of D (1.2 to 2.0
ig/l00 g/min in continuous i.v. infusion). Body weight, mean BP and
Hct were similar in three groups. Single nephron GFR (SNGFR) was
significantly decreased in Gr.II versus Gr.I (—38%, P < 0.01) due to the
marked glomerular vasoconstriction (afferent resistance, Ra, +60%, P
<0.05 and efferent resistance, Re, + 110%, P < 0.01 vs. Gr.I), with a
significant decrease of glomeruiar plasma flow (GPF, —44%, P < 0.01)
and to the striking fall of ultrafiltration coefficient (Kf, —41%, P <0.01).
In Gr.III D completely normalized SNGFR (P < 0.01 vs. Gr.II),
decreasing both Ra and Re to normal values (Ra, —70%, P < 0.05 and
Re, — 116%, P < 0.01 vs. Gr.II) and restoring GPF (P < 0.01 vs. Gr.II).
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D had beneficial effects on Kf, which was significantly increased both
versus Gr.II (+ 117%, P < 0.01) and versus Gr.I (+27%, P < 0.05). CsA
blood levels were similar in Gr.I1 and Gr. III. In conclusion, D
administration is effective in reversing the adverse hemodynamic ef-
fects acutely induced by CsA.
Peritoneal pore size determined by permselectivity studies. B. Di
Paolo, J. F. Maher, and A. Albertazzi, Institute of Nephrology, Uni-
versity of Chieti, Italy and Nephrology Division, Department of Med-
icine, USUHS, Bethesda, MD, USA. Peritoneal permeability has
traditionally been assessed by studies of mass transport rates of solutes
that vary in clearance being different in molecular mass and in spatial
configuration. Mass transport of small molecules may be retarded by
resistances in the blood path, in the dialysate and in the interstitium.
Quantifying the transport rates of large solutes like dextrans (dxt) which
are constant in configuration despite variation in size, we were able to
estimate the maximal pore size of peritoneum. In six, alert female New
Zealand white rabbits weighing 4.3 to 4.8 kg, peritoneal dialyses were
conducted by instilling through a percutaneously placed catheter 75 ml!
kg of dialysis solution containing 1.5% and 4.25% (separate studies)
dextrose monohydrate and a dextrose-free solution consisting of so-
dium bicarbonate and sodium chloride. Thirty minutes prior dialysis 1.0
g/kg of polydispersed neutral dxt 40, the range of which is 10,000 to
100,000 daltons, was injected i.v.; accordingly, peritoneal dialysis was
initiated 30 mm after injection. Sieving coefficients were calculated for
each dxt fraction by determining the difference in dxt clearances at
different rates of ultrafiltration (C1-C2)/UF1-UF2). A 1.5% dextrose
dialysis solution achieved mean clearances of dxt which ranged from
4.6 to 12.5 d/kgImin. As molecular mass increased from 17,000 to
50,000 daltons, clearances decreased linearly according to the regres-
sion, C = 13.2 dIkg/min — 0.00016 x daltons with a zero intercept at
83,000 daltons. With the glucose-free dialysis fluid, dxt clearances were
82% of the values with 1.5% dextrose dialysis fluid, but the relation of
clearance to molecular mass was similar. Above 50,000 daltons, the
clearance was 3.6 sl/kg/min. Clearance of the larger dxt were constant,
C = 4.21 dIkg/min — 0.00001 x daltons, intercepting zero at 440,000
daltons. With 4.25% dextrose dialysis fluid, below 50,000 daltons the
clearances decreased according to the formula, C = 23.0 sl/kgImin —
0.00032 x daltons, intercepting zero at 71,000 daltons. Above 50,000
daltons, dxt clearance averaged 6.4 l/kg/min. Transport of neutral
dextrans through the peritoneum should be representative of transport
rates and mechanisms of other large solutes of comparable dimensions,
such as proteins. A sharp decrement in mass transport would be
anticipated as a uniform pore size was approached. Our data did not
demonstrate such a change, but rather indicated a steady decline in
mass transport at all rates of ultrafiltration as dxt size increased,
consistent with heteroporosity of the peritoneum. The declining slopes
ended before reaching the zero intercepts, as a steady transport rate
independent of size was observed at all rates of ultrafiltration which is
compatible with pinocytosis. The intercept of the size-dependent trans-
port with that attributed to pinocytosis occurred at nearly identical
points on the abscissa, 52,000 daltons. This molecular mass is close to
so A, which is interpreted to be the maximal radius of the peritoneal
pores.
Parathyroidectomy has a beneficial effect on experimental cisplatin
nephrotoxicity. Giovambattista Capasso, Dario Ranieri Giordano, Na-
tale Gaspare De Santo, and Shaul G. Massry, Chair of Pediatric
Nephrology, Department of Pediatrics, University of Naples, Naples,
Italy, and Department of Nephrology, University of Southern Califor-
nia, Los Angeles, CA, USA. It has been recently suggested that
selective parathyroidectomy modifies drug-induced acute renal failure.
In the present study we have, therefore, tested if parathyroid hormone
(PTH) could play a role in the pathogenesis of cispiatin (CP) nephro-
toxicity. Parathyroidectomized rats (P1'X), but with normal blood
calcium, were injected with two different doses of CP (group Ia: 10 mg/
kg and group lb :6 mg/kg) and their renal functions were evaluated after
72 hours (group la) and 120 hours (group Ib), respectively. All animals
exhibited a milder course of acute renal failure when compared to
sham-PTX CP-treated rats, with lower serum creatinines (Scr) (group
Ia: 1.99 0.14vs. 2.91 0.56 mg/dl, P <0.05; group Ib: 1.45 0.08vs.
1.80 0.09mg/dl, P <0.05) and blood urea (BUN) (group La:76 5 vs.
115 l9mgldl,P<0.05;grouplb:70±9vs.88 lomg/dl,P<0.05).
Furthermore the i.p. administration of P'I'H (50 IU twice daily for 9
days) to normal rats treated with CP (6 mg/kg) made worse the CP
induced ARF as compared to vehicle injected animals (Sr 2.23 0.16
vs. 1.63 0.19 mg/dl, P < 0.05 and BUN 153 22 vs. 97 20 mgldl,P < 0.05). Finally the treatment with the calcium channel blocker,
verapamil (4 mg/kg), nine days before and three days after CP (4 mg/kg)
administration, had no significant effect on cisplatin nephrotoxicity.
These data indicate that selective parathyroidectomy ameliorates ex-
perimental, cisplatin-induced acute renal failure, while PTH may
worsen CF nephrotoxicity through a mechanism that is not mediated by
the voltage-dependent calcium channels.
In vitro and in vivo burst forming unit erythroid (BFU-E) response to
recombinant human erythropoietin (r.IIuEpo). C. Brunati, T. De Feo,
M. D. Cappellini, M. L. Perrino, C. Guastoni, A. Perego, U. Teatin,
M. Seveso, E. Minetti, G. Civati, and L. Minetti, Renal Unit, Niguarda
Ca Granda, Milan and Inst. Internal Medicin, University of Milan,
Milan, Italia. We followed the peripheral BFU-E in 6 uremic politrans-
fused females on dialytic treatment with marked anemia (mean Hb
pre-transfusion 5.9 0.6 g%) treated with high doses of r-HuEpo (300
to 525 U/kg/week) to reach Hb  10 g% out of transfusion. Peripheral
BFU-E from a control group had an increasing response to added
r-HuEpo in culture with a plateau at 4 U/mI (382.2 132 BFU-E/ml of
blood). In the uremic group the r-HuEpo dose response curve was
different from healthy: in 3 patients the maximal expression of BFU-E
was obtained with lower concentrations of r-HuEpo (0.5 2 U/mI).
BFU-E in the blood of the uremic patients before the start of r-HuEpo
treatment was 308.1 253/mI of blood. The number of BFU-E was
re-evaluated in all patients after 3 weeks of r-HuEpo and when 10 g% of
hemoglobin were reached. The number of BFU-E decreased during
r-HuEpo treatment in all patients reaching values lower than controls
(63.8 50/mi of blood). The reduction of the number of peripheral
BFU-E could be due to the maturation of these erythroid stem cells
because of the influence of r-HuEpo.
In vitro solubilization of glomerular IgG, IgA and C3 deposits after
incubation with high concentration human IgG solution. C. Cirami, L.
Casarosa, V. Panichi, A. M. Bianchi, M. Parrini, G. Grazi, A. Baronti,
R. Cominotto, and R. Palla, Medical Clinic 2nd Institute, University of
Pisa, Pisa, Italy. A study of the solubilization of glomerular deposition
of IgO, IgA and C3 in various nephntides by human IgG is described.
Patients: N = 36; 24 M, 12 F. Histologic patterns: 13 idiopathic
membranous GN (IMGN); 10 IgA nephropathy (IgAN); 5 S.L.E.GN; 2
membranous GN;3 diffuse proliferative; I focal giomerular sclerosis; I
interstitial nephritis; 1 renal vasculitis; I mesangiocapillary GN; I
mesangial proliferative GN; 3 minimal glomerular changes (MGC).
Renal biopsy specimens were stained with FICT conjugated, specific
human IgG, IgA and C3 antisera. Other serial sections of specimens
were incubated (37°C for 5 hr with mild constant shaking) with human
IgG (concentration 6 mg/mI or 2 mg/mI) or human albumin (40 mg/mI) or
PBS prior to staining procedure with FICT antisera. MCG specimens as
control were used. IgG and C3 deposition disappeared in all but 2
patients (with IMGN) after incubation with IgO 6 mg/mI solution. In
IgAN patients, IgA were removed only when the deposits were on the
capillary wall (3 pts); the mesangial pattern remained unmodified. Only
a IgG and C3 deposits lightening was caused by 2 mg/mI IgG solution
incubation. No variation in IgG, IgA and C3 fluorescent staining after
human albumin or PBS incubation was observed. High doses of human
IgG in vitro solubilize glomerular IgG, C3 and IgA capillary deposits by
physicochemical immunodeposit property changes. A steady binding of
IgA to mesangial structures may explain the nonsolubilization in most
IgAN patients.
Reflex non.osmotic control of AVP secretion in uremic patients on
chronic hemodialysis. C. Zoccali, F. Mallamaci, M. Ciccarelli, F.
Cuzzola, S. Parlongo, F. Salnitro, Divisione di Nefrologia and CNR,
Centro Fisiologia C/mica, Reggio Cal, Italy. Since volume-dependent
AVP secretion is regulated by the autonomic system it may be altered
in uremic patients with autonomic neuropathy. We have studied the
reflex AVP response to iso-osmotic fluid subtraction (by isolated UF) in
14 selected uremic patients on RDT: five with normal autonomic
function, three with moderate autonomic involvement (secondary to an
afferent lesion in two), and six diabetic uremics with advanced sympa-
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thetic-parasympathetic damage (two of which affected by a severe form
of hemodialysis hypotension). The UF rate was regulated so as to
equalize changes in right atrial pressure (RAP) and in mean arterial
pressure (MAP). In patients with normal or moderately affected auto-
nomic function, fluid subtraction (—3.37 + .86 liter in 90 + 8 mm)
caused a marked fall in RAP (from 13 + 3.5 to 3.6 + 2.6 cm H20) and
in MAP (from 113 + 22 to 86 + 39 mm Hg). These changes were
associated with a consistent increase in plasma AVP (from 4.3 + 2.5 to
8.7 + 3.6 pg/mI, P < 0.01). The response of the two patients with
afferent lesion was similar to that of patients with normal autonomic
function. In diabetic uremics, including those with HD-hypotension,
comparable changes in RAP (from 14 + 6 to 7 + 4 cm H20) and in MAP
(from 115 + 17 to 93 + 26 mm Hg) was achieved by subtracting an
identical fluid volume at slower UF rate (—3.2 + 0.98 liter in 117 + 7
mm) caused an equally consistent AVP response (from 3.5 + 1.5 to 8.0
+ 4.8 pg/mI). Reflex control of AVP is preserved even in the presence
of afferent neuropathy or advanced autonomic damage in uremic
humans. AVP does not seem involved in the pathogenesis of hemodi-
alysis hypotension.
Effect of gluconeogenic amino acids (AA), aianine and BCAA on renal
hemodynamics in humans. P. Castellino, R. A. DeFronzo, C. Giordano,
Yale University School of Medicine, New Haven, Connecticut, USA;
Instituto di Medicina Interna e Nefrologia, Universilá di Napoli,
Naples, Italy. In humans, hyperaminoacidemia induces a significant
rise in both GFR and RPF. At present it is not fully understood which
group of amino acid is involved in this response. In order to address this
question, we have evaluated the effect of separate groups of amino acid
on renal hemodynamics in 7 normal subjects (age 25 2, 107 3 %
IBW). Following three baseline determinations of GFR and RPF (inulin
and PAll clearances, respectively) the following groups of amino acid
have been administered intravenously for 180 mm. Study 1: giyconeo-
genic AA (Arg, Gly, Pro, Met, 1st, Ser); Study 2: Ala; Study 3: BCAA
(Val, Leu, lieu); Study 4: NaCI 0.9%. Plasma AA levels were compa-
rable in Study Ito 3 (basal 1772 77; 2564 128, 2809 101, 2443
91, 1733 53 (smol/liter in studies 1,2, 3, and 4). We have observed the
following variations in GFR and RPF, in mi/i .73 mt/min. (P <0.01 vs.
basal):
St. Bas 60' 120' 180'
GFR 1 98±6 112±8 1l4±8a ll3±8
2 98±3 104±6 106±7 108±9
3 95±6 104±6 103±7 105±5
4 100±7 98±10 99±9 98±9
RPF 1 4% 47 609 87 638 70 619 59
2 512 24 582 66 557 59 541 57
3 528 60 570 64 557 57 578 90
4 549 57 546 61 494 31 548 49
During hyperaminoacidemia we did not observe any significant
change in insulin and growth hormone concentrations. Glucagon levels
increased significantly only in Study 1(117 10 vs. 151 13 pg/mI, P
<0.05). These data indicate that, at a similar level of hyperaminoaci-
demia, gluconeogenic AA, but not Ala or BCAA, can elicit a significant
rise in GFR and RPF. These results indicate that factors other than the
absolute rise in plasma AA levels play a role in the renal hemodynamic
response to hyperaminoacidemia.
Immunohistochemical study by immunofluorescence and immunogold
immunodelectron microscopy of 7 cases with fibrillar nephropathy. U.
Donini, S. Casanova, P. Zucchelli, G. Monga, G. Mazzucco, R. P.
Linke, Divisione di Nefrologia e Dialisi, Laboratorio di Microscopia
Elettronica, Ospedale M. Malpighi, Bologna; Dipartimento di Scienze
Biomediche ed Oncologiche, Universiti di Torino, Torino, Italy: Insti-
tu: für Immunologie der Universität, D-8000 München, Federal Repub-
lic of Germany. Fibrillar nephropathy is characterized by proteinuria,
hematuria and arterial hypertension, associated with extracellular fi-
brillar glomerular deposits. These deposits, while not stained by Congo
red at light microscopy, resemble amyloid on electronmicroscopy; their
chemical nature has not yet been identified. We have immunohisto-
chemically studied the renal biopsies of 7 patients affected with fibrillar
nephropathy in order to characterize the chemical nature of their
glomerular deposits. Routine light, electron and immunofluorescence
microscopy was applied, and in addition the antigenic content of the
fibrillar deposits was analyzed in comparison with different amyloid
fibril proteins such as the AA, AA, At1, AF and AB. On cryostat
sections, the study was performed using the direct immunofluorescence
technique with FITC-conjugated antibodies against IgO, IgA, 1gM, C3,
fibrinogen, Clq and both ll and A light chains. On ultrathin Epon-
Araldite sections, the renal biopsies were studied by the immunoelec-
tronmicroscopic protein A-gold technique using antibodies against lgG,i and A light chains, and against the following amyloid fibril proteins:
AA (monoclonal antibody, mel), AA, A, AF and /32-microglobulins.
Two cases of amyloidosis (AA and AA), were used as controls. Using
immunofluorescence, all 7 cases studied showed intense staining of the
glomerular deposits for IgG and both ll and A light chains. Using
immunoelectronmicroscopy, no staining was evident with antibodies
against amyloid proteins, but the reaction was positive with antibodies
against lgG, ll and A light chains, with the gold particles being mainly
apparent close to the fibrils in the glomerular deposits. This data shows
that the non-amyloid fibrillar deposits we examined have antigenic
epitopes in common with IgG, but are also antigenically distinct from
amyloid fibrils of the AA, AA, Au, AF, and AB types.
Characterization of IgA immune complexes in IgA nephropathy and
coeliac disease. P. Mald,fassi, R. A. Sinico, A. Fornasieri, A. Ragni, M.
Caruso, G. D'Amico, Division of Nephrology, S. Carlo Hospital,
Milan, Italy. Increased serum levels of IgA antibodies to ubiquitous
dietary antigens (Ag) and IgA immune complexes (IgA-IC) have been
described in some patients with IgA nephropathy (IgAN) and in the
majority of children with coeliac disease, in whom renal involvement is
a rare event. To investigate whether lgA-CIC and 1gA antibodies to
food Ags have peculiar features in IgA nephropathy, we studied
igA-CIC (anti-C3 SP), IgA to dietary Ags (gliadin, ovalbumin, BSA,
casein, lactoglobulin: ELISA) and the Ag composition of IgA-CIC
(dissociation test in Ag excess and a specific ELISA for BSA-containing
CIC) in 9 IgAN patients with high serum levels of lgA to food Ags and
in 15 children with coeliac disease. Both groups had high levels of IgA
to dietary Ags. Six of 9 patients (66%) with IgAN and 9 of 15 (60%) with
coeliac disease had increased levels of IgA-CIC. The Ag(s) more
frequently involved in CIC composition was BSA in IgAN and milk
proteins and BSA in children with coeliac disease. Analysis of sera by
HPLC at neutral pH revealed that IgA to food Ags were distributed on
a broad range of molecular weight in both groups, which resolved in 2
main peaks (monomeric and polymeric IgA) upon dissociation. In
conclusion, there are no substantial differences in IgA to dietary Ags
and IgA-CIC in lgAN patients in comparison with coeliac disease.
Probably, other characteristics such as p.i. and/or different antibody!
antigen systems are involved in the pathogenesis of renal damage in
IgAN.
Estradiol and cyclophosphamide blunt oral tolerance and promote
nephritogenesis in experimental IgA nephropathy. L. Gesualdo, S. N.
Emancipator, M. E. Lamm, F. P. Schena. Institute of Pathology, Case
Western Reserve University, Cleveland, USA, and Chair of Medical
Therapy, University ofBan, Italy. Estradiol and cyclophosphamide can
blunt oral tolerance, which otherwise results in diminished IgG and 1gM
serum antibody in the presence of good IgA responses after chronic oral
immunization. Nephritogenesis after chronic oral immunization could
be promoted if instead there were sustained IgG and 1gM responses
(Lab Invest 52:269, 1987). Balb/c mice given drinking water containing
0.1% bovine gamma globulin (BOG) continuously for 14 weeks were
randomly assigned to 2 cohorts of 4 groups each (A,B,C,D). At weeks
6 and 10 the first cohort groups (A,B,C) received, respectively, 2 mg
cyclophosphamide intraperitoneally, 2 mg estradiol subcutaneously and
saline solution intraperitoneally. The second cohort groups (A,B,C)
received the same treatment but at 4 and 10 weeks. The group D
received neither BGG nor drugs and were controls. As we previously
observed a low percentage of mice orally immunized and given saline
had hematuria as did nonimmune controls. However, estradiol groups
(P < 0.025, P < 0.01) and the second cohort cyclophosphamide group
(P < 0.001) developed hematuria. These last groups also had more lgG
anti-BGG than control and saline groups (r2 = 0.992, P < 0.001).
immunofluorescence studies showed significantly more glomerular de-
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posits of IgG and C in estradiol groups (P <0.01, P <0.05) and in the
second cohort cyclophosphamide group (P < 0.01) compared to saline
and control groups. We conclude that glomerular IgG and/or 1gM
promote complement deposition and hematuria in IgA nephropathy and
that blunting of oral tolerance with promotion of systemic IgG and 1gM
antibody can promote nephritis in chronically, orally immunized mice.
Analogous defects in oral tolerance could play a role in human IgA
nephropathy.
Renal hyperfiltration in kidney donors: Its dependence on renal pros-
tacyclin. A. Pierucci, R. Tersigni, G. Stirati, S. Morabito, I. Carda-
mone, G. Ciabattoni, B. M. Simonetti, Division of Nephrology and
Department of Surgery, University of Rome "La Sapienza" and Dept.
of Pharmacology, catholic University School of Medicine, Rome,
Italy. Kidney donors (KD) for renal transplantation provide an oppor-
tunity to prospectively evaluate the compensatory hyperfiltration de-
veloping in remnant nephrons following renal ablation, the mechanism
of which is unknown. Since prostacyclin (PGI2) is a determinant of RBF
and GFR in human kidney, the aim of this work was to study in KD: I)
the influence of unilateral nephrectomy (UN) on GFR and renal PGI2
synthesis; and 2) GFR dependence on intact cyclooxygenase activity.
GFR (mutest) averaged 94 II (SD) mI/mm in 4 KD (1 male, 3 females,
age 40 to 49 years) pre-UN, 68 6 and 79 6 1 month and 1 year
post-UN, respectively. Urinary (U) 6-keto-prostaglandin (PG) Fi,,, a
reflection of renal P012 synthesis (Patrono et al, J Clin Invest 69:231,
1982) averaged 4.3 0.4 (SD) ng/hr pre-UN, 4.0 0.1 and 3.2 0.2 ng/
hr 1 month and 1 year post-UN, respectively. Single kidney GFR and
PG!2 synthesis rose 45% and 86% 1 month post-UN and 68% and 49%
1 year post-UN, respectively. U-2,3-dinor-6-keto-PGF1 (reflecting
extrarenal PG!2 sinthesis) was measured by a gas chromatography/mass
spectrometry-validated RIA technique (Ciabattoni et al, Adv PG, TX &
LTRes 17B:598, 1987): 393 128 (SD) pre-UN, 305 14 and 504 84
pg/mg creatinine I month and 1 year post-UN, respectively (P = NS).
GFR was unaffected by Ibuprofen (I) treatment (1.2 g/day x 7 days)
pre-UN (94 11 vs. 96 11 mI/mm) and 1 month post-UN (68 6 vs.
68 8 mI/mm) despite a > 50% reduction of renal and extrarenal PG!2
synthesis. In contrast, 1 year post-UN, I significantly reduced GFR by
24% (79 6 vs. 60 4 mI/mm, P < 0.01). We conclude that: a)
increased renal PG!2 synthesis is associated with increased function in
remnant kidney; b) the functional consequence of inhibition of renal
P012 synthesis at I month post-UN may be masked by a residual
functional capacity; c) since inhibition of renal PG!2 synthesis at 1 year
post-UN cannot be countered by such adaptive mechanism, already
fully activated, GFR drops. Thus, what differentiates healthy subjects
with two kidneys from those with one kidney is not only the "status"
of renal P012 synthesis, but also the possibility to compensate for its
reduced synthesis.
Critical ageing of silicone rubber peritoneal catheter. S. Ballocchi, P.
G. Poisetti, G. Bergonzi, F. Fontana, L. Scarpioni, Renal Unit,
Piacenza Hospital, Italy. Increased survival of patients treated by
CAPD is related to a long-term reliability of employed dialysis devices.
We analyzed 6 Tenckhoff peritoneal catheters by scanning electron
microscopy (SEM) and by infrared spectroscopy with attenuated total
refractance (ATR). In 5 cases the catheters made of silicone rubber
were removed after an average of 52 months because of the appearance
of external segment fissures. One, by Silastic with inclusions of barium
sulfate throughout the entire catheter to render it radio-opaque, was
removed after 49 months because of peritonitis. As control 3 catheters
of the same model which had never been used were analyzed; one of
these catheters were bathed in povidone-iodine solution and one in
sodium hypoclorite solution for a period of three months. The analysis
of extracorporeal portion of Silastic catheters showed by ATR an
oxidation peak more stressed on the external surface than on the
internal surface, by SEM sink marks and cracks on the external surface
and strong exfoliation and flattening of silastic reticle on the intralumi-
nal surface. The microanalysis of some exfoliation particles confirms
that these are exclusively composed by silicone. We did not find
evidence of oxidation in the intraabdominal portion of catheters, but
presence of fully cracked proteinaceous biofllm. Particularly, the ex-
tracorporeal portion of radio-opaque catheter showed by SEM deep
cracks with widespread sinks and craters. The catheters immersed in
disinfectant solutions did not show any changes. We suppose that
barium sulfate could render the silicone rubber brittle and that environ-
mental long-term factors (such as UV-rays, temperature, sweat, dialy-
sate pH, disinfectants) could cause oxidation and loss of chemical-
physical property, with critical silicone ageing and lessening of catheter
strength to mechanical failure.
Use of tissue adhesive in the Tenckoff catheter implantation. P. G.
Poisetti, M. Pisani, F. Montagni, G. Bergonzi, S. Ballocchi, F.
Fontana, Renal Unit and Department of Surgery, Piacenza Hospital,
Italy. Peritoneal catheter site leakage is common during the early period
of peritoneal dialysis (the incidence differing 5 to 37% among the
Authors, as 14.7% of our all cases). In order to eliminate this compli-
cation we have made ready a new placement technique, an improve-
ment of the one generally used in our center. In 8 patients (37 to 74
years) treated with chronic peritoneal dialysis (6 CAPD and 2 !PD) we
have placed, by surgery, as many curled Tenckhoff catheters, with two
dacron felt cuffs, presoaked in saline, with a transverse laparotomy in
the McBurney spot on the left side. The placement procedure provides
the insertion of the first cuff below muscle fascia in the prepentoneal
tissue, continuous non-absorbable suture sewed around the cuff, suture
completing with thin layer of assorbable histological adhesive. This is
composed by butyl-cianoacrylate manomer in fluid state which poly-
merizes in contact with the tissues, solidifying in a few seconds and
producing protective barrier. Then the catheter is passed through a
medial counter-split of the fascia of external oblique muscle towards
subcutaneous tunnelling. In all eight patients no leakage occurred
during early catheter utilization 3 to 6 hours after operation. Only a
cirrhotic patient, with increased bleeding tendency, showed a small
hematoma in the subcutaneous tunnel. In conclusion, the advantages of
this placement technique are: closing of suture channels, high tissue
adhesive resistance, the rapid forming of a protective film counter to
bacteria, prompt catheter utilization and simple execution.
Dextran deposits in tissues of patients undergoing hemodialysis. G.
Bergonzi, G. Bassallo, C. Paties, A. Zambianchi, P. G. Poisett, S.
Ballocchi, F. Fontana, G. Crippa, L. Scarpioni. Renal Unit and
Department of Clinical Pathology, Piacenza Hospital, Italy. Dextran
(DX) at 40,000 molecular weight is used as a plasma expander in the
treatment of intradialytic hypotension. Despite the fact that DX is
mainly eliminated through the kidney, the lack of demonstration of
accumulation in tissues did not prevent its use in patients (pts) with
severe impairment of the renal function. In order to evaluate a possible
DX storage we studied histological specimens of 43 pts on regular
hemodialysis (32 pts treated with DX and 11 treated with other plasma
expanders, such as gelatin or mannitol, during intradialytic hypoten-
sion). In the 11 pts who received higher doses of DX (0.38 g per kg of
body weight per week) we found inclusions in the cytoplasm of
macrophages of various organs (liver, spleen, lung, heart, bone, bowel
and parathyroid). These inclusions, with a diameter ranging from 2 to 20
resulted PAS positive and Diastase resistant on light microscopy,
birefringent on polarization microscopy, with a fibrillar structure at
transmission electron microscopy. Microanalysis with electronic probe
on scanning electron microscopy, showing peaks for calcium and
phosphorus, excluded the presence of silicon. No macrophagic inclu-
sions were observed in the control group of pts treated with other
plasma expanders instead of DX as well as in the pts given DX doses
0.08 g per kg of body weight per week. In 11 pts presented with
storage of PAS positive material we found a linear correlation between
the doses of given DX and amount of inclusions. A clinical picture
characterized by persistent fever, hypotension, weight loss, abdominal
pain, dysphagia and scleroderma-like syndrome has been found in 2 out
of the 11 positive pts. Clinical symptoms regressed after stopping DX
administration. According to our data, we suggested the withdrawal of
DX in routine use for hemodialyzed pts.
Measurement of inactive renin with monoclonal antibodies may con-
tribute to clarify its physiological significance. P. Ferraris, P. Quorso, L.
Turolo, E. Pulazzini, C. Sala, A. Morganri, Istituto di Clinica Medica
Generale e Terapia Medica, Università di Milano e Centro di Fisiologia
Clinica e Ipertensione, Ospedale Maggiore, Milano, Italy. The physi-
ological significance of inactive renin (IR) is still unclear. This may due,
in part, to difficulties in accurately measuring IR with the conventional
enzymatic assay, particularly when active renin (AR) is very high.
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Determination of JR with an immunoradiometric assay (IRMA) employ-
ing specific monoclonal antibodies may obviate this limitation of the
enzymatic assay. Thus, we compared the effects of the acute adminis-
tration of 25 mg Captopril (C) on enzymatic (E, ng/ml/hr) and immuno-
reactive (Ir, pg/mI) AR and JR in nine patients with renovascular
hypertension. Measurements of E and Ir renins were performed before
and after activation of plasma with sepharose-bound trypsin, the blood
samples being collected before and 30, 60, 90 and 120 minutes after C.
Before C, EAR and IrAR were respectively 24.6 11.1 ng/mllhr and
438 215 pg/mI, whereas EIR and IrIR were 28.8 9.7 and 199 36.
After C both EAR and lrAR rose progressively, reaching a peak
(respectively 61.1 18.7 and 748 319) at 60 mm, i.e. concomitantly
with the peak of the blood pressure response, and remaining elevated
up to 120 mm after C (53.9 15.7 and 659 261). These increments in
EAR and IrAR were significant with respect to baseline values (P <
0.01) and correlated with each other (r = 0.88, P < 0.01). However,
after C, ELR decreased not significantly to 24. 2 8.1 and 21.3 5.8 at
60 and 120 mm whereas, at the same times, IrIR decreased to 101 28
and 139 15 (P < 0.05 for both). In addition, the changes in AR and IR
were inversely related with both methods (P < 0.01); however, the
correlation coefficient was higher with the IRMA than with the E assay
(—0.79 vs. —0.65). Thus, the reciprocal changes or IrAR and IrIR reveal
a possible conversion between the two forms of the enzyme which was
not clear with the E method. It is concluded that the measurement of
renins by IRMA may contribute to a better understanding of the
physiology of the renin system.
Oral calcium load: Diagnostic value and physiopathologic effects. P.
Messa, G. Mioni, L. Paganin, D. Montanaro, M. Adorati, M. Messa,
Institute of Nephrology, Urology City Hospital Udine, Italy. Oral
calcium load is still the most widely used method for roughly assessing
the intestinal absorption of Ca (I.Ca A.) by the induced changes in
urinary Ca excretion (Ca/Cr). However, other factors may affect the Cal
Cr after an oral Ca load (e.g. the changes in bone turnover rate). We
tested the reliability of Ca load in predicting I.Ca. A. and its metabolic
effects on bone turnover in 45 patients (32 stone farmers and 13 patients
with primary hyperparathyroidism; 20 F, 25 M, aged 18 to 70 years).
After an equilibration period on a 500 mg Ca diet, the following
parameters were evaluated: 1. Ca A. (by kinetic methodology using
SrCl2); seric and urinary Ca, hydroxyprolinuria (uOHP), urinary cAMP
and TmPi/GFR before and after a standard oral Ca load (I g). The
results are expressed as mean SD. Basal values of!. Ca A were shown
to be scattered over a wide range (32—92%; mean SD 62.5 13.2; n.y.
30—60). Table I shows the values of the other studied parameters bgfore
and after the Ca load. A significant reduction of urinary OHP excretion






Pre 0.141 9.93 32.14
16.55
4.98
Post 0.200 10.63 24.17 5.80
P 0.0003 0.0001_— 0,0008 NS
shown. The changes Ca/Cr induced by Ca load were then correlated, by
a stepwise multiple regression, with the following independent varia-
bles: I. Ca A., basal uOHP, delta uOHP and delta sCa. The results are
shown in Table 2. The !.Ca A. is shown not to have any statistical
significant weight on the changes of Ca/Cr. On the other hand the
changes in bone turnover (uOHP) and to a lesser extent the basal uOHP










conclusion: I.) Changes in Ca/Cr after a standard oral Ca load are not
predictive of the degree of 1. Ca A. 2) The oral Ca load induces
significant changes in bone turnover and these changes may play a
predominant role in affecting the extent of changes in urinary excretion
of Ca.
Parameters of hemostasis activation in nephrotic syndrome. A. Sagri-
panti, A. Cupisti, F. Ciardella, M. Ferdeghini, E. Pinori, G. Barsotti.
/st Medical Clinic, Department of Nephrology, Department of Hema-
thology, and Nuclear Medicine Service, University of Pisa, Pisa, Italy.
Thromboembolic accidents are very common in nephrotic patients. The
aim of this study is to assess the degree of blood coagulability and of
platelet activation by measuring some specific parameters of hemostasis
activation in the nephrotic patient. Fibrinopeptide A (FPA), (a sensitive
index of in vivo thrombin activity), beta-thromboglobulin (beta-TG) and
Platelet Factor 4 (PF4), (two platelet specific alpha-granule proteins
released in plasma during platelet activation), have been determined in
26 adult patients affected by nephrotic syndrome, and in 32 healthy
controls. Ten of the patients had values of creatinine clearance <60 ml/
mm, the remaining had normal renal function. No one presented
clinical, laboratory or instrumental signs of thrombosis. FPA was 2.49
1.36 ng/ml in the pts and 1.09 0.54 ng/ml in the controls (P < 0.001);
TG was 60.1 32 ng/ml in the pts and 25.7 7.4 ng/ml in normals (P
<0.001); PF4 did not differ between the two groups (6.5 3 ng/ml vs.
5.4 1.6 ng/ml). A negative correlation was observed between TG and
creatinine clearance (Pearson correlation coeff.: 0.49, P < 0.05),
Patients with creatinine clearance >60 mI/mm had TG values higher
than the control group (P < 0.001). In vitro FPA generation test
(according to Nossel) was performed in 18 pts: delta FPA was 0.97
0.51 ng/mI/lO mm without any difference from normals; these results
suggest a local, but not systemic, activation of hemostasis. In two
patients calcium-heparmn therapy (12,500 LJ.I./l2 hr) was followed by a
significant decrease of FPA (from 6.55 to 1.74 ng/ml, and from 2.90 to
1.44 ng/ml, respectively), indicating that the increase of FPA was
thrombin-mediated and that thrombin was generated in sites accessible
to heparin. In conclusion, an accelerated fibrin-formation process and!
or an activation of circulating platelets was present in almost all studied
patients; such alterations, together with hyperlipemia, may play a role
in the pathogenesis of the thrombotic complications of the nephrotic
syndrome.
Prevention and treatment of aluminum (Al) overload: Long term
results. C. Canavese, A. Pacitti, M. Saloinone, G. Mangiarotti, A.
Thea, L. Gurioli, G. P. Segoloni, A. Vercellone. Department of
Nephrology, University of Torino, Italia. The pivotal bases for a
protocol of prevention and treatment of Al overload in uremic patients
are constituted by: I) checking Al levels in patient serum (AIs); 2)
minimizing Al concentrations in dialytic solutions; 3) looking for Al-free
phosphate binders; 4) using the test with desferrioxamine (DFO) in
order to disclose tissue Al surcharge before any clinical symptoms; 5)
employing DFO as prevention and treatment in patients with DFO test
positive or frank Al intoxication. The aim of this study was to evaluate
the efficacy of this protocol in our RDT patients in a follow-up of 7
years. The study started with 164 RDT patients (1981) and stopped with
161 RDT patients (1988). Eighty-one patients were monitored from the
beginning until the end of follow-up. AId and in Als were determined
every 6 and 12 months, respectively. Al hydroxide (AH) used as
phosphate binder was tapered and substituted by Mg hydroxide (MgH)
1 to 2 g!day, and Ca carbonate (CaC) 2 to 5 g/day. DFO = test (50 mg/
kg) was performed in all patients with Als > 60 < 100 .eg/liter. Basal Als
levels > 100 zg/liter were found in 22% of patients in 1981, but in
nobody in 1988, while the percentage of values <60 pg/liter increased
from 55 to 91%. DFO test was positive in 54% and 7% of cases,
respectively in 1981 and 1988. AId was always <25 sg/liter. A clinical
diagnosis of Al intoxication was performed in 6 patients in 1981, and no
further cases were successively diagnosed. DFO treatment (50 mg/kg
once a week) was employed in 31 patients as prevention owing to
DFO-test positive, and in the 6 Al intoxicated patients as therapy. In
these latter, Al removal strongly decreased after 3 years, and clinical
improvement was only temporary in the three parathyroidectomized
patients. In 1988, 66% of patients employed CaC or MgH alone or in
association while 34% still needed AH, though at low dosages (2 g/





of Al intoxication. A particular caution is needed with respect to
parathyroidectomy in Al overloaded patients, not only because it may
exacerbate the clinical symptoms, but also because it may reduce the
therapeutic efficacy of DFO.
Schdnlein-Ilenoch disease in children and adults. F. Fatone, A.
Vangelista, D. Martella, A. M. Bonifati, M. G. Frascà, V. Bonomini.
Institute of Nephrology, St. Orsola University Hospital, Bologna, Italy.
SchOnlein-Henoch (S-H) is considered a disease mainly affecting pedi-
atric patients. Renal involvement is present in 20% to 90% of patients,
and renal prognosis correlates with the degree of renal lesions at the
Onset of the disease. This study deals with the clinical-morphological
findings at the onset and the long-term follow-up (5 to 84 months)
observed in 24 pediatric patients aged 3 to 15 years (group A) and 13
adults aged 18 to 72 years (group B) who had S-H disease and signs of
renal involvement. At the onset, the clinical picture was: ARF in 3
patients (12.5%) from group A and in 4 patients (30%) from group B;
nephritic syndrome in 41% of patients in group A and 30% in group B;
nephrotic syndrome in 16% of patients, all from group A: isolated
proteinuria or minimal urinary changes were observed in the remainder.
Renal biopsy showed the presence of crescents affecting over 60% of
the glomeruli in 2 children and 1 adult patient. Diffuse proliferative
lesions were observed in 41% of patients in group A and 30% in group
B; necrotizing lesions were associated to proliferation in 29% and 15%
of patients, respectively. Focal proliferation was present in the remain-
der. At the end of follow-up: in group A complete remission was
observed in 3 patients; nephrotic syndrome in 2; only I child progressed
to CRF, and arterial hypertension was present in one patient with
normal renal function. All the other children showed only minimal
urinary changes. In group B, 2 patients had CRF, proteinuria without
nephrotic syndrome was observed in 2 patients, arterial hypertension in
3, minimal urinary changes in 5. Only one patient completely recov-
ered, Our results show that S-H disease may be associated with variable
clinical pictures at onset both in children and adults. The incidence of
ARF is higher in adult patients. Renal biopsy shows different histolog-
ical lesions, the incidence of which does not significantly vary in either
group. The long-term follow-up suggests more favorable prognosis in
children, and confirms the relationship between initial renal lesions and
the progression of the disease.
The role of atrial natriuretic peptide (ANP) in volume homeostasis in
the nephrotic syndrome (NS). P. Stratta, C. Canavese, M. Dogliani, C.
Massara, P. C. Brossa, A. Censon, F. Pluviano, A. Vercellone. De-
partment ofNephrology, Service of Nuclear Medicine, University of
Torino, Italy. The pathogenesis of water-sodium retention in NS is still
not completely understood. A role for ANP has been suggested because
intrarenal targets for ANP seem to be located in distal tubular portions,
the same districts which are involved in the intrarenal defect of sodium
excretion in NS. The aim of the study was to evaluate the behavior of
ANP in NS before and after volume changes by albumin infusion. The
study was undertaken in 10 adult patients with NS following different
nephropathies (3 LES, 2 membranous, 2 focal glomerulosclerosis, 2
amiloydosis, 1 minimal changes, I mesangiocapillary, I light chain
nephropathy). Blood and urine specimens were obtained before and
after 20% albumin infusion (0.3 to 0.4 glkg). We evaluated: ANP
(RIA-Peninsula), aldosterone (A, RIA-Travenol), creatinine clearance
Ccr, Na and K) excretion (UN and UK), sodium fractional excretion
(FENa), Osmolar clearance (Com), proteinuria (U) and hematocrit(Hct). Basal ANP was not significantly different from normal range
(29.4 2 vs. 30 pg/mI), while A was increased (187 200 pg/nI) but
with a very large standard deviation. After albumin, a diuretic and
natriuretic response was observed in 7 patients, but not in the other 3.
In the responders, UNa, UKand FeNa significantly increased (from 50
2 to 133 60 d/min, from 24 2 to 42 6 p1/rn and + 117 60%,
respectively) together with BCcr an C0,, (from 57 2 to 78 6 mI/mm
and from 1.0 2 to 1.9 0.4 mI/mm, respectively). ANP also
significantly increased (from 24 3 to 35 6 pg/mI) while A signifi-
cantly decreased (from 199 20 to 19 2 pg/mI). Conversely, in
nonresponders, ANP did not increase, though both HcT and A de-
creased. We conclude that ANP may mediate the natriuretic response
to albumin in NS, and an inadequate ANP increase may be responsible
for nonresponder cases. A/ANP ratio is a better index than ANP alone
in evaluating sodium excretion in NS.
Effects of thromboxane A2 (TxA2) on inositol phosphates, cytoplasmic
free Ca2 ([Ca21.) and pH (pH1) in human mesanglal cells in culture. P.
Mené G. A. Cinotti, M. J. Dunn, Departments of Medicine, Divisions
of Nephrology, University of Rome, Italy, and University Hospitals,
Cleveland, Ohio, USA. TxA2 synthesized by renal cells, leukocytes and
platelets is a major mediator of glomerular inflammation. Its potent
contractile effects on intra- and extraglomerular smooth muscle result in
impaired renal blood flow and glomerular filtration rate. In the present
study we analyzed putative intracellular signals for TxA2 in cultured
human mesangial cells. The stable TxA2 mimetic, U-46619, stimulated
the accumulation of the metabolites of the membrane phospholipid
phosphatidylinositol, inositol tris- (1P3), bis- (1P2), and monophosphate
(1P1), measured after anion exchange chromatography in [3H]-inositol-
labeled cultures (1P3 + 50.4 9.9% at 10 sec, P < 0.05 vs. basal; 1P1 +
371.6 64.7%, lP2 + 96.9 17.8% at 15 mm, P < 0.05). U-46619
simultaneously stimulated an increase of [Ca2]1, measured by fluores-
cence excitation of fura-2-loaded cells, from baseline levels of 79 4 to
1015 126 nM within 10 sec. The increase of (Ca2]1 resulted from the
release of intracellular stores, since it was not inhibited by chelation of
extracellular Ca2 with EGTA, which however accelerated reversal to
normal levels. Fluorometric measurements of pH in BCECF-loaded
cells demonstrated a rapid acidification, simultaneous to the [Ca2]1
rise, from 7.03 0.03 to 6.9 0.04, followed by prolonged alkaliniza-
tion to a maximum of 7.11 0.03. Removal of extracellular Na or
preincubation of the cells with 1 mt,i amiloride inhibited alkalinization,
indicating a Na/H countertransport. These effects on cytosolic ionic
fluxes of mesangial cells in culture suggest the presence of functional
receptors in vivo, and provide a biochemical basis for the glomerular
vasoconstriction associated with elevated intrarenal TxA2 biosynthesis.
Renal tubular function and Bence Jones proteinuria. M. E. De Ferrari,
G. Colussi, C. Airaghi, E. Benazzi, P. Rolando, L. Barbarano, E. E.
Minetti, L. Minetti, Divisioni di Nefrologia e Dialisi e di Ematologia,
Ospedale Niguarda Ca' Granda, Milano, Italy. Experimental and
clinical evidence suggests that light chain proteinuria might impair renal
tubular function. The aim of our study was to evaluate the prevalence,
type and clinical relevance of functional tubular abnormalities in pts
with plasma cells dyscrasias. Eighty-seven unselected, prospective
patients were investigated, 37 with detectable Bence Jones protein in
urine (BJP, K in 20 and A in 17). BJP-positive patients (BJP-pos) had
significantly higher f32-microglobulin fractional excretion (4.1 8.5%, P
<0.01) and amino acid urine excretion (960 470 mg/g Cr, P < 0.02),
and lower Ccr (73 39 mI/mm, P < 0.001) than both BJP-negative
patients (BJP-neg: 0.08 0,1%, 738 296 mg/g Cr and 94 32 mI/mm
respectively) and 35 sex- and age-matched controls (0.04 0.05%, 707
232 mg/g Cr and 106 39 mI/mm, respectively). No parameter in
BJP-negative patients was statistically different than in controls. Ten
BJP-pos had significantly higher lithium clearance (22.7 8.1 mI/dI
GFR, P < 0.05), distal Na reabsorption (22.4 7.3 mI/dI GFR, P <
0.05) and maximal CH2O after an oral water load (9.4 1.6 mI/dI GFR,
P < 0.02), and significantly lower minimal Uosm after oral water load
(55.1 lO.3mOsm/kgH2O,P<0.0l)than I8BJP-neg(16.5 5.8, 15.9
4.1 and 6.9 2.3 mI/dI GFR, and 74.4 16.5 rnOsm/kg H20,
respectively), indicating decreased proximal tubule reabsorption and
increased distal delivery and reabsorption of Na/fluid. In BJP-pos there
was a statistically higher prevalence, in comparison with BJP-neg, of
abnormal tubular reabsorption of the following proximally reabsorbed
solutes: /32-microglobulin, amino acids, glucose, phosphate, uric acid,
bicarbonate. No differences were seen between patients with K or A
BJP, and no relation was found between tubule abnormalities and the
amount of BJP; moreover, the pattern of tubular abnormalities was
quite variable in individual patients, and only in 3 patients at least
4 transport abnormalities were associated. There were no significant
differences in GFR and the amount of BJP between BJP-pos with
or without tubule transport abnormalities. These results indicate that:
I) there is a significant association between BJP and tubule abnormal-
ities, which appear to be unrelated to both the immunotype and the
amount of individual BJP's; 2) the pattern of tubular abnormalities
appears to be quite variable in individual patients: a "generalized"
proximal or pantubular disfunction appears to be the exception rather
than the rule.
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Polycations and biological membranes In MCN: Misinterpretation and
perspectives. F. Ginevri, G. Candiano, G. M. Ghiggeri, R. Oleggini, R.
Bertelli, F. Perfumo, C. Queirolo, R. Gusmano. G. Gaslini Institute,
Nephrology Department, Genoa, Department of Internal Medicine,
Hospital of Lavagna, Italy. The polycation Alcian Blue (AB) has been
utilized for measuring the surface charge of biological membranes in
normal and pathological states, assuming the full ionization of AB at
physiological pHs and an electrostatic interaction of the dye with
membrane polyanions. The decrease in its binding to erythrocyte ghosts
and GBM in MCN and focal glomerulosclerosis has been interpreted as
a signal for a generalized defect in membrane anionic charges. We have
employed bidimensional electrophoretic titration curves for monitoring
the effective charge of AB along a pH gradient between 3.5 and 9 and
the interaction of the dye with either globular proteins not having sialic
residues, and membrane proteins of various sources. The following
salient points have been raised: I) AB is not ionized at pHs between 6
and 7.8 due to a strong interaction with itself that is inhibited by
switerionic (CHAPS) detergents or ethyl-urea but not by nonionic
molecules or urea. 2) The same interaction occurs between AB and
globular proteins, such as hemoglobin and myoglobin, and to a low
extent with extracts from erythrocyte ghosts and GBM. These obser-
vations demonstrate that the binding of AB with biological membranes
cannot be taken as a measure of their anionic charge. Other and more
complex forces such as hydrophobicity can be involved in this interac-
tion. These or unknown factors may be involved in the decrease affinity
of AB for erythrocyte ghosts in MCN and focal glomerulosclerosis.
Treatment of experimental membranous glomerulonephrltis (Hey-
mann's nephritis) with receptor antagonists of Platelet-activating factor
(PAF). G. Salvidio, J. Van Liew, G. Camussi, J. Brentj ens. Istituto
Scientifico di Medicina Interna, Section of Nephrology, University of
Genoa, Genoa, Italy, and Department of Physiology and Department
of Microbiology and Pathology, Slate University of New York at
Buffalo, Buffalo, New York, USA. PAF is a lipid mediator with a broad
range of biological activities relevant in inflammation. PAF is released
during glomerular inflammatory injury such as acute serum sickness
and in situ-formed immune complex exudative glomerulonephritis. PAF
may potentially increase glomerular permeability directly or through
the recruitment of inflammatory cells and may modify glomerular
hemodynamics as result of its contractile effects on mesangial cells.
Treatment with PAF receptor antagonists in two different models of
experimental immune glomerular disease, namely nephrotoxic nephritis
(Bertani T et al, Kidney mt 31:1248, 1987) and in situ-formed immune
complex exudative glomerulonephritis induced by implantation of Ca-
tionized antigen in the glomerular capillary wall (Camussi G et al, I Lab
Clin Med 110:1%, 1987) prevented proteinuria, inflammation and de-
crease in renal function. We report here the effect of treatment with two
PAF receptor antagonists, SRI-63072 and SRI-63675, 2.5 mg/100 g/24 hr
(Sandoz Res. Inst., East Hannover) of passive Heymann's nephritis
induced by injection of 10mg of sheep anti-brush border IgG in 23 LEW
rats. Protein and creatinine concentrations were measured at 24 hr
intervals and the urinary protein excretion rate of protein and creatinine
clearance were determined. Rats were sacrificed at day 7. Proteinuria in
rats treated with SRI-63072 (187.0 85.9 at day 7) and with SRI-63675
(118.2 37.1 mg/24 hr at day 7) were not significantly different from
untreated controls (178.0 88.5 mg/24 hr at day 7) during the whole
period of observation. These results differ from those obtained in
nephrotoxic nephritis and in the in situ-formed immune complex
exudative glomerulonephritis and suggest that PAF does not play a role
in increased glomerular permeability in Heymann's nephritis, a leu-
kocyte-independent, complement-dependent glomerular disease. PAF
seems rather involved in experimental diseases dependent from the
recruitment of leukocytes such as nephrotoxic nephntis and in situ
formed, immune complex exudative glomerulonephntis.
Experimental IgA nephropathy induced by oral immunization in Lewis
and Wistar rats. S. N. emancipator, L. Gesualdo, M. E. Lamm, F. P.
Schena. Institute of Pathology, Case Western Reserve University,
Cleveland, Ohio, USA, and Chair of Medical Therapy, University of
Ban, Italy. IgA nephropathy is an immune complex glomerulonephritis
developing from mucosal antigen penetrating the body in the face of a
predominantly IgA immune response, at least in one mouse model we
developed. This model is of limited utility for pathophysiologic study,
since mouse glomeruli can be isolated with at best 50% purity, impeding
study of the inflammatory mediators. Hemodynamic studies are impos-
sible in mice because of the size of their vessels. We sought to adapt our
established murine model to rats to allow pathophysiologic studies. We
studied four strains of rats (Wistar, Lewis, Sprague-Dawley, Fisher) to
determine which has the best IgA response. Rats from each strain were
separated in two groups (A, B). Groups A were orally immunized by
substituting drinking water with 0.1% solution of bovine gamma glob-
ulin (BGG) in 6 m acetic acid continuously; Groups B did not receive
oral BGG and were controls. After 6 weeks, all the groups received an
intravenous challenge with 10 mg/day of BGG, for 3 successive days.
As we previously observed in mice (Lab Invest 57:269, 1987) orally
immunized and intravenously challenged rats had hematuria, particu-
larly Wistar and Lewis strains (P < 0.025 and P < 0.01, respectively),
significantly more than control rats. Orally immunized Lewis rats had
38.9- and 36.3-fold more and Wistar rats 2.98- and 2.4-fold more IgA
and IgG serum antibody than controls, respectively. The same immu-
nized strains showed IgA and IgG glomerular deposits (P < 0.025). In
conclusion, we have developed experimental IgA nephropathy in rats,
particularly in Lewis and Wistar strains; this model will allow the study
of hemodynamics and pathophysiology in rats and hopefully give more
insight into the pathologic events in human IgA nephropathy.
